ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stephens, J. W.
Right arrow Articles by Ward, W. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stephens, J. W.
Right arrow Articles by Ward, W. K.

Ann Thorac Surg 1988;45:544-547
© 1988 The Society of Thoracic Surgeons

Articles

The Effect of Glucose Priming Solutions in Diabetic Patients Undergoing Coronary Artery Bypass Grafting

J.W. Stephens, M.D., A.H. Krause, M.D., C.A. Peterson, P.A., C.C.P., J.J. Bass, M.D., J.E. Hartman, M.D., N.W. Salomon, M.D., W.K. Ward, M.D.*

From the Divisions of Endocrinology, Cardiothoracic Surgery, and Anesthesiology, Good Samaritan Hospital and Medical Center, Portland, OR

Accepted for publication November 24, 1987.

* Address reprint requests to Dr. Ward, 2232 N.W. Pettygrove, Portland, OR 97210

To assess the impact of glucose-containing priming solutions on plasma glucose level in diabetic patients during and after coronary artery bypass graft surgery, we studied 50 diabetic patients and 10 nondiabetic patients who underwent bypass graft surgery. Glucose-containing priming solutions profoundly elevated plasma glucose levels during and after bypass graft surgery. In diabetic patients who received glucose primes, intraoperative peak plasma glucose levels averaged 696 ± 48 mg/dl as compared with 341 ± 17 mg/dl in diabetic patients who received nonglucose primes (p < 0.001). Despite an insulin infusion, diabetic patients underwent a much slower decline in plasma glucose levels postoperatively over a 2-hour period than did nondiabetics (who did not receive an insulin infusion). We conclude that during and immediately after coronary artery bypass surgery in diabetic patients, it is desirable to avoid administration of glucose-containing priming solutions, since such solutions profoundly elevate plasma glucose levels.




This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. P. Furnary, G. Gao, G. L. Grunkemeier, Y. Wu, K. J. Zerr, S. O. Bookin, H. S. Floten, and A. Starr
Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 1007 - 1021.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
P. A Gustafson, D. L Zarro, D. A Palanzo, N. J Manley, R. M Montesano, M. Quinn, B.-A. Elmore, and J. M Castagna
Conventional approach to glucose management for diabetic patients undergoing coronary artery bypass surgery
Perfusion, March 1, 2002; 17(2): 141 - 144.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. W. Stephens, A. H. Krause, C. A. Peterson, J. J. Bass, J. E. Hartman, N. W. Salomon, and W. K. Ward
The effect of glucose priming solutions in diabetic patients undergoing coronary artery bypass grafting
Ann. Thorac. Surg., May 1, 1995; 59(5): 1259 - 1260.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 by The Society of Thoracic Surgeons.